EPI to support international research of coronavirus variants
The Emerging Pathogens Institute and partner GHESKIO join the VERDI project to understand global coronavirus genetic variants in the COVID-19 epidemic.
The Emerging Pathogens Institute and partner GHESKIO join the VERDI project to understand global coronavirus genetic variants in the COVID-19 epidemic.
A new model compares how various rapid antigen tests could be optimized with quarantine and surveillance efforts to reduce transmission of the SARS-CoV-2 virus that causes COVID-19.
A UF researcher collaborated on a model estimating how an alternate delta-driven surge scenario would have played out if at least 74% of Florida's adults were vaccinated against COVID-19 by mid-summer.
Genomic sequence analysis of the SARS-CoV-2 strains currently circulating in Florida and Alachua County, Fla. as of Sept. 27, 2021.
UF researchers estimate what COVID-19 infections, cases, and deaths may look like in Florida in the coming months.
Compared with the U.S., why are some countries less affected by COVID-19? A UF researcher leads a team looking for answers in Africa. “If we can learn what can protect us as a species, we could potentially be better prepared for the next pandemic," said Rhoel Dinglasan, professor of infectious diseases.
A new study found that 35% of all COVID-19 cases are asymptomatic. Children are most likely to lack symptoms, while the elderly are least likely.
Genomic sequence analysis of the SARS-CoV-2 strains currently circulating in Florida and Alachua County, Fla. as of Sept. 27, 2021.
A team of UF researchers has identified dozens of novel therapeutic targets for the development of antiviral therapies against COVID-19 and other coronaviruses that infect people.
UF biostatisticians estimate what the delta variant-driven surge in COVID-19 infections may look like in Florida in the coming months.